Christa Knox Email & Phone Number

Texas

• Launched two commercial products: an innovative chaperone therapy for an ultra-orphan, genetic condition, Fabry Disease, and combination oral/infused treatment for Pompe Disease• Establish site of care for patients; educate infusion centers on product administration • Work in partnership with Geneticists, Genetic Counselors, Nephrologists, Neurologists, and Cardiologists in Texas• Develop thought leaders and collaborate with colleagues to educate on disease states• Advise healthcare providers on genetic testing program to assist in determining amenable patients • Received “Top of the Fold” Award for 2022 Territory Performance• Top performer, increasing territory through strategic planning and targeting; 103% growth in 2020 over 2019; 111% growth in shipments in Q1 and 102% in Q2 and 115% in Q4 2021, in addition to increasing patient referrals • Selected to serve on Field Advisory Committee for 2020, representing the commercial team

Texas, Oklahoma

Focused on ultra-rare disease in the Neurology /Neuromuscular therapeutic area. Launched a treatment for an inherited, genetic condition within a new commercial sales force. • New commercial launch team promoting treatment for an ultra-rare, genetic disorder, Primary Periodic Paralysis• Drove demand from Neurology/Neuromuscular, Nephrology and Endocrine specialists throughout Texas and Oklahoma• Educated providers, nurses and managers on product and prescription process, coding, and reimbursement• Launched genetic testing program to assist in identifying patients with Primary Periodic Paralysis• Collaborated with the Muscular Dystrophy Association, connecting patients to available resources• Worked closely with our Specialty Pharmacy partner to distribute product swiftly, benefiting the patient

Texas, Oklahoma

Previously NPS Pharmaceuticals, Ultra-Rare Disease Area Business Specialist, promoting a sub-cutaneous injection supporting patients with Short Bowel Syndrome (SBS). Work with multiple specialists, including Gastroenterologists and Surgeons and patient organizations.Collaborate with and educate Specialty Infusion Pharmacies, Dieticians and Pharmacists.Achieved 167% to goal for first half of 2016; Surpassed sales goals for second half 2016Continuously exceeded sales goals; Top performer Regionally and Nationally

Texas, Arizona, New Mexico, Arkansas

One of twelve Managers that generated business for an infused biologic treatment for kidney transplant patients. Educated Transplant Nephrologists, Surgeons, hospital Pharmacists and Purchasing Agents, Assisted Transplant Financial Coordinators and Social workers with coverage options and maintaining patients on therapy.Achieved 300% growth in product sales and vial sales by 50%

Texas, Oklahoma, Arkansas

Distinctive sales role that promoted a TKI for the treatment of rare Chronic Myeloid Leukemia (CML). Worked with Specialty Pharmacies and an independent patient resource center to increase patients' drug access. Responsible for a large territory. Drug removed from US market in October 2013, resulting in sales force elimination.

Texas, Oklahoma

Promoted position with additional role responsibilities and leadership opportunities. Top performer within the Nation from product launch through 2013

Texas, Oklahoma, Arkansas, Louisiana

Ultra-Orphan Rare Disease specialized sales role representing a new class of biologic, infused treatment for the Hereditary Angioedema (HAE). Worked closely with internal team members and externally Specialty Pharmacies to assist patients. Ranked #1 in 2009 for new patient prescriptions; Ranked #1 for product vials sales for 2009, 2010 and 2011. Ranked #4 out of 24 for overall sales in 2012. Ranked #3 out of 32 in 2013.

Dallas/Fort Worth Area

Dallas, Texas

Bachelor'S Degree, Sociology

Mba, Health Services Management

Master Of Business Administration - Mba, Health Services Management